Türkiye’s leading pharmaceutical company, Abdi Ibrahim Pharmaceuticals, is collaborating with AronPharma, a significant European company that produces innovative products in the dietary supplement sector. Abdi İbrahim has signed an agreement to acquire the sales and distribution rights for Aronpharma’s Berroxin brand products in Türkiye.
Nezih Barut, Chairman of the Board of Directors at Abdi İbrahim, emphasized the importance of the consumer health products market in the company’s future vision, which has been dedicated to improving lives for 111 years. Barut highlighted the value of their collaborations in this field and expressed excitement about bringing Berroxin brand products to Turkish consumers. He stated, “We are excited to introduce Turkish consumers to Berroxin brand products. With this agreement, we offer a reliable and innovative portfolio in a category where competition and market saturation are high. This collaboration indicates our commitment to sustaining success not only in prescription products but also in the consumer health category. It is also a significant step towards rapidly achieving our international goals in this field. We will continue to invest in strengthening our power and vision in the consumer health sector in the coming periods without slowing down.”
